Bob Langer-founded cell therapy player loads up $65M to fund Roche-partnered cancer work while expanding into vaccines for infectious diseases
SQZ Biotech isn’t planning to test anything against Covid-19 for now. But when the next pandemic strikes, CEO Armon Sharei wants its cell therapy platform …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.